The analysis of the clinical and biological outcomes of the subgroups of NASH patients from the learning datasets showed that the subgroup with high MMP9 mRNA level had higher hepatic fat content, inflammation, BMI, NAS, leptin and adiponectin levels and this subgroup mainly included female patients (Fig. 5C). The gene discussed is MMP9; the disease is metabolic dysfunction-associated steatohepatitis.